Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

3 large caps near 52-week lows with large dividends: https://www.marketbeat.com/logos/articles/med_20240126063229_3-large-caps-near-52-week-lows-with-large-dividend.jpg
3 large caps near 52-week lows with large dividends

How fitting that Thursday night’s full moon was also referred to as the ‘wolf moon.’ 

U.S. stock indices howled to fresh all-time highs this week as the first full moon of 2024 lit up the evening

Abbott Laboratories on track for new highs in 2024: https://www.marketbeat.com/logos/articles/med_20240125084342_chart-abt-1252024ver001.png
Abbott Laboratories on track for new highs in 2024

Abbott Laboratories (NYSE: ABT) share price fell following its Q4 2023 results, but investors should be cheering the news. The decline is a response to a report that was largely as expected, with

Super Micro Computer hits record high ahead of its earnings: https://www.marketbeat.com/logos/articles/med_20240125082645_super-micro-computer-hits-record-high-ahead-of-its.jpg
Super Micro Computer hits record high ahead of its earnings

Super Micro Computer (NASDAQ: SMCI), a major standout in the tech stock arena, experienced a remarkable 36% surge last Friday, reaching a new all-time high after the stock broke out of a

The EV bubble burst: Tesla looks to the future but wait to buy in: https://www.marketbeat.com/logos/articles/med_20240125072305_chart-tsla-1252024ver001.png
The EV bubble burst: Tesla looks to the future but wait to buy in

If the last year of price cuts and sluggish sales weren’t enough to tip off the market to the fact the EV bubble has burst, Tesla’s (NASDAQ: TSLA) Q4 results and outlook for 2024 should do it. The

When does 3M’s stumble become a buy?: https://www.marketbeat.com/logos/articles/med_20240125070519_when-does-3ms-stumble-become-a-buy.jpg
When does 3M’s stumble become a buy?

Having put in what looked like a bottom last October, investors in 3M Co (NYSE: MMM) would have been looking ahead to 2024 with bullish optimism. Sure, the stock had sunk 60% since the summer of

This one wireless service stock could blow past earnings: https://www.marketbeat.com/logos/articles/med_20240124122029_this-one-wireless-service-stock-could-blow-past-ea.jpg
This one wireless service stock could blow past earnings

Now that the Federal Reserve (the Fed) has pivoted its strategy to the opposite end of where it had been throughout 2023, meaning they are now proposing to cut interest rates after an aggressive

Verizon and AT&T: One is a high-yield value, the other a trap: https://www.marketbeat.com/logos/articles/med_20240124114037_chart-vz-att-1242023ver001.png
Verizon and AT&T: One is a high-yield value, the other a trap

Verizon Communications Inc. (NYSE: VZ) and AT&T Inc. (NYSE: T) have presented value and yield to investors for years. 

However, they failed to sustain interest in their stocks, creating a drag on

These 5 growth stocks are now in buy ranges: https://www.marketbeat.com/logos/articles/med_20240125065914_these-5-growth-stocks-are-now-in-buy-ranges.jpg
These 5 growth stocks are now in buy ranges

Chart patterns and consolidations are worth watching, as they provide actionable guidance for making a purchase. 

With the recent uptrend in large-cap stocks, as reflected by the performance of

Food fight! Which grocery store stocks will win in 2024?: https://www.marketbeat.com/logos/articles/med_20240124122319_food-fight-which-grocery-store-stocks-will-win-in.jpg
Food fight! Which grocery store stocks will win in 2024?

Food distributors and retailers are living up to their reputation as the best consumer staples industry to own. 

Up 2.1% year-to-date, the group has a sizable early lead over its roughly flat sec

Intuitive Surgical’s post-earnings dip is a healthy time to buy: https://www.marketbeat.com/logos/articles/med_20240124145004_chart-isrg-1242024ver001.png
Intuitive Surgical’s post-earnings dip is a healthy time to buy

Intuitive Surgical (NASDAQ: ISRG) share prices surged following the Q4 release but failed to hold the gain, creating an ugly candle capping a strong rally. The market may move lower from here, but

5 top healthcare stocks for earnings growth in 2024: https://www.marketbeat.com/logos/articles/med_20240124120518_5-top-healthcare-stocks-for-earnings-growth-in-202.jpg
5 top healthcare stocks for earnings growth in 2024

While the healthcare sector delivered lackluster profit growth in 2023, it should change this year. 

Sector components forecast to show the biggest earnings year-over-year earnings improvement

Why Apple’s about to smash through $200 and continue: https://www.marketbeat.com/logos/articles/med_20240124111807_why-apples-about-to-smash-through-200-and-continue.jpg
Why Apple’s about to smash through $200 and continue

Microsoft Corporation (NASDAQ: MSFT) recently overtook Apple Inc. (NASDAQ: AAPL) as the world's most valuable company while also setting its all-time high; expectations are high for Apple to make

Will leverage and pricing power drive Netflix to a record high?: https://www.marketbeat.com/logos/articles/med_20240124071952_chart-nflx-1242024ver001.png
Will leverage and pricing power drive Netflix to a record high?

The Netflix Inc. (NASDAQ: NFLX) narrative is not without risk. The company struggled with growth following the COVID-19 bubble, but those days are behind. The story today is leverage, driven by

3 just-upgraded energy stocks to put on your radar: https://www.marketbeat.com/logos/articles/med_20240124085415_3-just-upgraded-energy-stocks-to-put-on-your-radar.jpg
3 just-upgraded energy stocks to put on your radar

Last night saw the S&P 500 index close at a fresh all-time high. It's a remarkable achievement that didn't look as likely as recently as October. But since the prospect of a rate cut became quite

Eilt: Institutionelle Investoren begeistert von innovativer Krebstherapie. Massives Kaufsignal.  Neuer 199% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73356/Aktiencheck240124_01.001.png
Eilt: Institutionelle Investoren begeistert von innovativer Krebstherapie. Massives Kaufsignal. Neuer 199% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Großinvestoren begeistert von innovativer Krebstherapie. Neuer 199% Biotech Aktientip nach 15.973% mit BioNTech

 

24.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

Insiders buy Alibaba stock after $278 billion stimulus. What now?: https://www.marketbeat.com/logos/articles/med_20240123115954_insiders-buy-alibaba-stock-after-278-billion-stimu.jpg
Insiders buy Alibaba stock after $278 billion stimulus. What now?

Every once in a cycle, the market experiences hysteria, whether on the upside or the downside. These are some of the best moments to pick a direction to expose your portfolio to potentially

3 reasons to buy Meta stock ahead of earnings: https://www.marketbeat.com/logos/articles/med_20240123084749_3-reasons-to-buy-meta-ahead-of-earnings.jpg
3 reasons to buy Meta stock ahead of earnings

Meta Inc (NASDAQ: META) reports Thursday of next week in what will be one of the more closely watched reports of the year so far. The tech giant ended 2023 on a high, and its rally has, for the

Three defensive stocks to hedge your risks this year: https://www.marketbeat.com/logos/articles/med_20240122121644_three-defensive-stocks-to-hedge-your-risks-this-ye.jpg
Three defensive stocks to hedge your risks this year

As the new market cycle starts, a few uncertainties come with how the Federal Reserve (the Fed) will potentially cut interest rates. Some traders still need to buy the promises, judging by how

Why the market is overpaying for Netflix stock ahead of earnings: https://www.marketbeat.com/logos/articles/med_20240122130616_why-the-market-is-overpaying-for-netflix-stock-ahe.jpg
Why the market is overpaying for Netflix stock ahead of earnings

Never fight the market, and remember that the trend is your friend. This is why Netflix (NASDAQ: NFLX) stock should be flashing across your watchlist today. The trend in this stock shows a

Ceragon is the under-the-radar networking stock you should know: https://www.marketbeat.com/logos/articles/med_20240121161314_chart-crnt.jpg
Ceragon is the under-the-radar networking stock you should know

Ceragon Networks Ltd. (NASDAQ: CRNT) is a provider of high-performance wireless infrastructure solutions to cellular operators and wireless service providers. It offers wireless backhaul solutions

Sarepta Therapeutics Inc.: Why it's a rising gene therapy star: https://www.marketbeat.com/logos/articles/med_20240121162239_chart-srpt.jpg
Sarepta Therapeutics Inc.: Why it's a rising gene therapy star

Sarepta Therapeutics Inc. (NASDAQ: SRPT) is a leading commercial-stage biotech focused on developing precision gene therapy treatments for rare diseases. This medical sector company specializes in

3 top rated Chinese stocks in prime value territory: https://www.marketbeat.com/logos/articles/med_20240122130243_3-top-rated-chinese-stocks-in-prime-value-territor.jpg
3 top rated Chinese stocks in prime value territory

As China's economy continues to face headwinds entering the new year, recent data has unveiled a harsh stock market sell-off, impacting U.S.-listed Chinese stocks such as Alibaba (NYSE: BABA),